C21 Investments Inc. (CSE:CXXI)

Market Cap	47.22M +51.3%
Revenue (ttm)	46.02M +16.8%
Net Income	-4.12M
EPS	-0.03
Shares Out	118.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Average Volume	25,650
Open	0.4200
Previous Close	0.4050
Day's Range	0.3950 - 0.4400
52-Week Range	0.1500 - 0.6800
Beta	2.05
RSI	41.20
Earnings Date	Jan 28, 2026

About C21 Investments

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 138
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CXXI

Financial Performance

In fiscal year 2025, C21 Investments's revenue was $30.12 million, an increase of 12.42% compared to the previous year's $26.79 million. Losses were -$3.97 million, 789.2% more than in 2024.

Financial numbers in USD